Revolutionizing Hemophilia Treatment: FDA Approves Fitusiran, Offering Hope with Qfitlia March 29, 2025
Revolutionizing Hemophilia Treatment: FDA Approves Innovative RNA-Based Therapy Qfitlia March 29, 2025
Nkarta Restructures for Resilience: A Strategic Shift Towards Autoimmune Cell Therapy Amid Industry Challenges March 28, 2025
Nkarta Restructures for Survival: A Bold Shift Towards Autoimmune Therapies Amidst Market Challenges March 28, 2025
Nkarta’s Strategic Restructuring: Charting a New Course in Autoimmune Therapy Amid Market Challenges March 28, 2025
Nkarta Restructures Workforce and Leadership to Focus on Autoimmune Cell Therapies Amid Market Challenges March 27, 2025
Nkarta Restructures for Survival: A Bold Pivot Towards Autoimmune Cell Therapies Amidst Market Challenges March 27, 2025
Groundbreaking FDA Approval of Vykat XR: A Game-Changer for Prader-Willi Syndrome Treatment March 27, 2025
